Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
Background. Increasing body mass index (BMI) is associated with increased risk of mortality; however, quantifying weight gain in men undergoing androgen deprivation therapy (ADT) for prostate cancer (PC) remains unexplored. Methods. Between 1995 and 2001, 206 men were enrolled in a randomized trial...
Saved in:
Main Authors: | Lior Z. Braunstein, Ming-Hui Chen, Marian Loffredo, Philip W. Kantoff, Anthony V. D'Amico |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2014/230812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
by: Kristene Myklak, et al.
Published: (2011-01-01) -
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
by: Rahul Aggarwal, et al.
Published: (2022-01-01) -
Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
by: Katherine Neubecker, et al.
Published: (2017-01-01) -
Weight Gain, Obesity, and Psychotropic Prescribing
by: Nikhil Nihalani, et al.
Published: (2011-01-01) -
The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
by: Michael J. Smith, et al.
Published: (2012-01-01)